Bogart Wealth LLC lifted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) by 951.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,504 shares of the pharmacy operator's stock after purchasing an additional 1,361 shares during the period. Bogart Wealth LLC's holdings in Walgreens Boots Alliance were worth $57,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Rise Advisors LLC purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth $27,000. Iron Horse Wealth Management LLC lifted its position in shares of Walgreens Boots Alliance by 56.0% during the 1st quarter. Iron Horse Wealth Management LLC now owns 635 shares of the pharmacy operator's stock worth $28,000 after purchasing an additional 228 shares during the last quarter. GoalVest Advisory LLC lifted its position in shares of Walgreens Boots Alliance by 10,828.6% during the 2nd quarter. GoalVest Advisory LLC now owns 765 shares of the pharmacy operator's stock worth $29,000 after purchasing an additional 758 shares during the last quarter. City State Bank acquired a new stake in Walgreens Boots Alliance during the 4th quarter worth $30,000. Finally, Tompkins Financial Corp raised its stake in Walgreens Boots Alliance by 215.7% during the 1st quarter. Tompkins Financial Corp now owns 947 shares of the pharmacy operator's stock worth $42,000 after acquiring an additional 647 shares in the last quarter. 57.33% of the stock is owned by hedge funds and other institutional investors.
Get
Walgreens Boots Alliance alerts:
Wall Street Analyst Weigh In
Several equities research analysts recently commented on the stock. Truist Financial cut their price target on shares of Walgreens Boots Alliance from $50.00 to $42.00 and set a "hold" rating on the stock in a research note on Friday, July 1st. JPMorgan Chase & Co. cut their price target on shares of Walgreens Boots Alliance from $52.00 to $45.00 and set a "neutral" rating on the stock in a research note on Friday, July 8th. Barclays cut their price target on shares of Walgreens Boots Alliance from $50.00 to $45.00 and set an "equal weight" rating on the stock in a research note on Friday, June 24th. Credit Suisse Group dropped their price objective on shares of Walgreens Boots Alliance from $52.00 to $43.00 and set a "neutral" rating on the stock in a research note on Friday, July 1st. Finally, Royal Bank of Canada dropped their price objective on shares of Walgreens Boots Alliance from $46.00 to $42.00 and set a "sector perform" rating on the stock in a research note on Tuesday, July 5th. One equities research analyst has rated the stock with a sell rating and nine have issued a hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $45.75.
Walgreens Boots Alliance Trading Down 0.5 %
Shares of Walgreens Boots Alliance stock opened at $31.40 on Monday. Walgreens Boots Alliance, Inc. has a 52-week low of $31.23 and a 52-week high of $55.00. The company has a quick ratio of 0.43, a current ratio of 0.78 and a debt-to-equity ratio of 0.35. The company's 50-day simple moving average is $36.70 and its 200-day simple moving average is $40.58. The firm has a market cap of $27.14 billion, a price-to-earnings ratio of 5.06, a price-to-earnings-growth ratio of 1.36 and a beta of 0.64.
Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) last issued its quarterly earnings results on Thursday, June 30th. The pharmacy operator reported $0.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.95 by $0.01. Walgreens Boots Alliance had a net margin of 4.00% and a return on equity of 16.20%. The business had revenue of $32.60 billion for the quarter, compared to analyst estimates of $32.23 billion. During the same period in the previous year, the business posted $1.51 earnings per share. The business's revenue was down 4.2% compared to the same quarter last year. As a group, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 5.02 earnings per share for the current year.
Walgreens Boots Alliance Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, September 9th. Stockholders of record on Friday, August 19th were paid a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 6.11%. This is a positive change from Walgreens Boots Alliance's previous quarterly dividend of $0.48. The ex-dividend date was Thursday, August 18th. Walgreens Boots Alliance's payout ratio is 30.97%.
Walgreens Boots Alliance Company Profile
(Get Rating)
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Read More
- Get a free copy of the StockNews.com research report on Walgreens Boots Alliance (WBA)
- Archer Daniels Midland: Dividend Hero With 49 Years Of Increases
- Will Fully Autonomous Tractors Make Deere the Tesla of Farming?
- Magna International is Your Auto and EV One-Stop Shop Stock
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.
